Multicenter Phase II Study of Apatinib in Patients With Advanced Breast Cancer(CABC006)
Clinical trial NCT02878057 · COMPLETED
Trial details
- NCT number
- NCT02878057
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2020-09-02
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.